share_log

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Benzinga ·  Apr 10 20:09

Gainers

  • IN8bio (NASDAQ:INAB) stock increased by 47.7% to $1.61 during Wednesday's pre-market session. The market value of their outstanding shares is at $69.6 million.
  • Jaguar Health (NASDAQ:JAGX) shares rose 25.0% to $0.11. The company's market cap stands at $31.0 million.
  • China SXT Pharmaceuticals (NASDAQ:SXTC) shares moved upwards by 24.85% to $2.16. The market value of their outstanding shares is at $1.2 million.
  • Adial Pharmaceuticals (NASDAQ:ADIL) shares increased by 23.06% to $1.39. The market value of their outstanding shares is at $5.6 million.
  • iSpecimen (NASDAQ:ISPC) stock increased by 13.96% to $0.24. The company's market cap stands at $2.1 million.
  • Akebia Therapeutics (NASDAQ:AKBA) stock increased by 11.03% to $1.71. The market value of their outstanding shares is at $358.0 million.

Losers

  • BioSig Technologies (NASDAQ:BSGM) shares fell 13.0% to $1.41 during Wednesday's pre-market session. The market value of their outstanding shares is at $13.1 million.
  • Cocrystal Pharma (NASDAQ:COCP) shares fell 10.97% to $1.38. The company's market cap stands at $14.0 million.
  • Synaptogenix (NASDAQ:SNPX) shares declined by 8.52% to $4.52. The company's market cap stands at $4.9 million.
  • Kineta (NASDAQ:KA) stock fell 7.12% to $0.4. The market value of their outstanding shares is at $4.3 million.
  • Biophytis (NASDAQ:BPTS) stock declined by 6.57% to $0.39. The company's market cap stands at $4.4 million.
  • Addex Therapeutics (NASDAQ:ADXN) shares decreased by 6.42% to $26.11. The market value of their outstanding shares is at $27.6 million.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment